Location History:
- Collonge-Bellerive, CH (2014)
- Geneva, CH (1989 - 2015)
Company Filing History:
3 out of 32 
3 out of 25 
2 out of 1,048 
Years Active: 1989-2015
Title: Innovations in Diagnosis: The Contributions of Denis Francois Hochstrasser
Introduction: Denis Francois Hochstrasser, an accomplished inventor based in Geneva, Switzerland, has made significant strides in the field of diagnostics, particularly focusing on brain damage-related disorders and Alzheimer's disease. With a remarkable total of 14 patents to his name, Hochstrasser's work has advanced our understanding of critical medical conditions.
Latest Patents: Among his latest innovations are two notable patents. The first patent relates to a diagnostic method for brain damage-related disorders, which involves detecting specific polypeptides or their variants in body fluid samples from subjects. This method is particularly relevant as it distinguishes polypeptide levels in cerebrospinal fluid of deceased patients versus healthy donors, providing a valuable tool for diagnosis. The second recent patent addresses biomarkers for diagnosing Alzheimer's disease, offering a method to assess and monitor the progression of the disease through the detection of specific peptide markers, often utilizing mass spectrometric analysis.
Career Highlights: Denis has worked with reputable organizations such as Electrophoretics Limited and the University of Geneva. His experience in these institutions has not only enriched his professional journey but also contributed to significant advancements in medical diagnostics.
Collaborations: Throughout his career, Hochstrasser has partnered with notable colleagues, including Jean-Charles Sanchez and Willy Vincent Bienvenut. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the quality and impact of his inventions.
Conclusion: Denis Francois Hochstrasser stands out as a key figure in the realm of medical diagnostics. His innovative approaches in identifying brain damage-related disorders and Alzheimer's disease through advanced methods are shaping the future of diagnosis. With a strong portfolio of patents and impactful collaborations, Hochstrasser continues to contribute to significant advancements in healthcare.